Your browser doesn't support javascript.
loading
Outpatient Motor Retraining for Functional Movement Disorder: Predictors of a Favorable Short-Term Response.
Callister, Marcus N; Klanderman, Molly C; Boddu, Sayi P; Moutvic, Margaret A; Geissler, Elizabeth N; Traver, Katie J; Staab, Jeffrey P; Hassan, Anhar.
Afiliação
  • Callister MN; Department of Neurology Mayo Clinic Scottsdale Arizona USA.
  • Klanderman MC; Department of Quantitative Health Sciences Mayo Clinic Scottsdale Arizona USA.
  • Boddu SP; Mayo Clinic Alix School of Medicine Scottsdale Arizona USA.
  • Moutvic MA; Department of Physical Medicine and Rehabilitation Mayo Clinic Rochester Minnesota USA.
  • Geissler EN; Department of Physical Medicine and Rehabilitation Mayo Clinic Rochester Minnesota USA.
  • Traver KJ; Department of Physical Medicine and Rehabilitation Mayo Clinic Rochester Minnesota USA.
  • Staab JP; Department of Psychiatry and Psychology Mayo Clinic Rochester Minnesota USA.
  • Hassan A; Department of Neurology Mayo Clinic Rochester Minnesota USA.
Mov Disord Clin Pract ; 10(9): 1377-1387, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37772308
Background: Treating functional movement disorder (FMD) with motor retraining is effective but resource intensive. Objectives: Identify patient, disease, and program variables associated with favorable treatment outcomes. Methods: Retrospective review of the 1 week intensive outpatient FMD program at Mayo Clinic in Minnesota from February 2019 to August 2021. Outcomes included patient-reported measures (Canadian Occupational Performance Measure-Performance and Satisfaction subscales [COPM-P and COPM-S, range 0-10] and Global Rating of Change [GROC, -7 to +7]) and a retrospective investigator-rated scale (0-3, worse/not improved to significantly improved/resolved). Linear regression models identified variables predicting favorable outcomes. Results: Participants (n = 201, 74% female, mean age = 46) had median FMD duration of 24 months. The commonest FMD subtypes were gait disorder (65%), tremor (41%) and weakness (17%); 53% had ≥2 subtypes. Most patients (88%) completed a therapeutic screening process before program entry. Patient-reported outcomes at the end of the week improved substantially (COPM-P average change 3.8 ± 1.9; GROC post-program average 5.5 ± 1.7). Available investigator-rated outcomes from short-term follow-up were also positive (102/122 [84%] moderately to significantly improved/resolved). Factors predicting greater improvement in COPM-P were completing therapeutic screening, higher number of non-motor symptoms, shorter FMD duration, earlier program entry, lower baseline COPM scores, and (among screened patients) higher GROC between therapeutic screening and program start. Conclusion: Patients with diverse FMD subtypes improved substantially over a 1 week period. Utilization of therapeutic screening and greater improvement between therapeutic screening and program start were novel predictors of favorable outcomes. Non-motor symptoms did not preclude positive responses, although patients with predominant non-motor burden were excluded.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Ano de publicação: 2023 Tipo de documento: Article